Breiter Capital Management’s ResMed RMD Stock Holding History

Breiter Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$493K	Hold	2,031	–	–	0.24%	82
2021 Q4	$529K	Hold	2,031	–	–	0.26%	82
2021 Q3	$535K	Sell	2,031 -23	-1%	-$6.29K	0.31%	80
2021 Q2	$506K	Buy	+2,054	New	+$432K	0.27%	81
2021 Q1	–	Sell	-2,054	Closed	-$437K	–	111
2020 Q4	$437K	Buy	+2,054	New	+$410K	0.3%	80

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Breiter Capital Management's RMD Position: Q1 2022 in Review

Breiter Capital Management held its ResMed (RMD) position steady in Q1 2022 at 2,031 shares worth $493K. The position accounts for 0.24% of the portfolio, ranked #82.

Breiter Capital Management first reported a position in RMD in Q4 2020 and has held it in 5 quarters since. The position peaked at $535K in Q3 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

Breiter Capital Management held 2,031 shares of ResMed worth $493K as of Q1 2022.
Breiter Capital Management left its ResMed share count unchanged in Q1 2022.
ResMed made up 0.24% of Breiter Capital Management's portfolio in Q1 2022, its #82 holding.
Breiter Capital Management first reported a position in ResMed in Q4 2020 and has held it in 5 quarters since.
Breiter Capital Management's ResMed position peaked at $535K in Q3 2021.
682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on Breiter Capital Management's 13F filing for Q1 2022, filed 11 May 2022.